MedTrace Logo

Treatment of Comorbid Depression and Substance Abuse in Young People

NCT00232284 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-06-26

No results posted yet for this study

Summary

This study aims to treat young people with an adjunctive integrated cognitive behavioral therapy (CBT) intervention and to examine the acceptability of this treatment approach within this population. The study will also include a pilot placebo-controlled trial of sertraline for those young people who fail to or only partially respond to the CBT intervention, so as to determine whether adjunctive anti-depressant treatment improves clinical response in this population.

Conditions

Interventions

DRUG

sertraline

RCT of sertraline/placebo for those young people who fail to respond within first 4 weeks of study entry

BEHAVIORAL

Cognitive Behavioural Therapy

An integrated 10-week CBT program for depression/anxiety and comorbid substance use

Sponsors & Collaborators

  • Dan Lubman

    lead OTHER

Principal Investigators

  • Dan Lubman · ORYGEN Youth Health, University of Melbourne, Department of Psychiatry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00232284 on ClinicalTrials.gov